PFPhoenix Financial Ltd.

Institutional investor · Portfolio as of Q3 2022

Top Holdings349 positions

Checking export access…
Activity:
XLVXLV
ETF

SELECT SECTOR SPDR TR

2.2M$267.4M5.9%$117.59-3.60%
11 qtrssince 2020-Q1
Increased
70
BUGBUG
ETF

GLOBAL X CYBERSECURITY ETF

8.7M$210.9M4.6%$28.80-17.48%
8 qtrssince 2020-Q4
Increased
63
KBWBKBWB
ETF

INVESCO KBW BANK ETF

3.8M$188.6M4.2%$55.97-19.64%
6 qtrssince 2021-Q2
Increased
60
TEVATEVA
ADR

TEVA PHARMACEUTICAL INDS LTD

20.8M$162.9M3.6%$8.81-11.25%
13 qtrssince 2019-Q3
Increased
63
PPHPPH
ETF

VANECK PHARMACEUTICAL ETF

2.2M$149.2M3.3%$70.45-12.31%
3 qtrssince 2022-Q1
Increased
55

Microsoft Corp.

579,265$137.6M3.0%$204.47+10.23%
13 qtrssince 2019-Q3
Increased
70

WELLS FARGO CO NEW

3.2M$129.4M2.9%$38.52-5.63%
6 qtrssince 2021-Q2
Increased
74
XLYXLY
ETF

Select Sector Spdr Trust STATE STREET CONSUMER DISCRETIONARY SELECT SECTOR SPDR ETF

806,104$117.1M2.6%$68.810.00%
1 qtr
New
78

HESS CORP

1.1M$116.2M2.6%——
3 qtrssince 2022-Q1
Decreased
0

AMCOR PLC

10.5M$112.6M2.5%$46.910.00%
1 qtr
New
78

ICL GROUP LTD SHS

11.5M$94.4M2.1%$6.69+2.77%
10 qtrssince 2020-Q2
Increased
51

F M C CORP

858,617$91.6M2.0%$97.66-3.85%
4 qtrssince 2021-Q4
Increased
54

Walmart Inc

692,310$91.6M2.0%$44.05-6.32%
11 qtrssince 2020-Q1
Decreased
0
AZNAZN
ADR

ASTRAZENECA PLC

1.6M$86.6M1.9%$102.94-0.68%
8 qtrssince 2020-Q4
Increased
52
IYZIYZ
ETF

ISHARES U.S. TELECOMMUNICATIONS ETF

4M$84.2M1.9%$24.45+75.81%
3 qtrssince 2022-Q1
Unchanged
0

PERION NETWORK LTD SHS NEW

3.8M$75.9M1.7%$20.40-2.63%
10 qtrssince 2020-Q2
Increased
53
IHFIHF
ETF

ISHARES U.S. HEALTHCARE PROVIDERS ETF

290,644$75.3M1.7%$49.12-0.46%
5 qtrssince 2021-Q3
Increased
75
KREKRE
ETF

STATE STREET SPDR S&P REGIONAL BANKING ETF

1.2M$71.5M1.6%$54.27-1.18%
10 qtrssince 2020-Q2
Increased
47
XBIXBI
ETF

STATE STREET SPDR S&P BIOTECH ETF

895,065$70.6M1.6%$115.28-31.96%
5 qtrssince 2021-Q3
Decreased
0

SUNRUN INC COM

2.4M$67.3M1.5%$49.73-44.66%
12 qtrssince 2019-Q4
Decreased
0
$4.5B
AUM
349
Positions
Q3 2022
Filing
HI score · 3.5/5
Quarterly 13F Value Change
+16%Q2'21$5.1B+9%Q3'21$5.6B+5%Q4'21$5.9B-3%Q1'22$5.7B-17%Q2'22$4.8B-5%Q3'22$4.5B
Activity profile
$ moved · Q3'22
New17%Increased28%Decreased37%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 years
<1Q4%1-4Q21%1-2Y28%2Y+47%

Phoenix Financial Ltd. manages $4.5B across 349 positions as of Q3 2022. Top holdings: XLV (5.9%), BUG (4.6%), KBWB (4.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3.5/5.0.

Q3 2022 Summary

Active quarter - 17 new positions, 41 exits, 128 increased. Top move: XLY (NEW, conviction 78). Portfolio: $4.5B across 349 positions.

Top holdings by portfolio weight

Total AUM$5B
XLV5.89%
BUG4.65%
KBWB4.16%
TEVA3.59%
PPH3.29%
MSFT3.03%
WFC2.85%
XLY2.58%
HES2.56%
AMCR2.48%
Other2.08%

Portfolio allocation by GICS sector

Sectors11
Unknown44.85%
Technology17.96%
Financial Services8.92%
Healthcare8.62%
Communication Services4.73%
Consumer Cyclical4.68%
Basic Materials4.42%
Industrials3.04%
Consumer Defensive2.16%
Utilities0.31%
Other0.30%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(3.5 / 5.0)
Holdings P&L51
Conviction44
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
CLBTCLBTCELLEBRITE DI LTD
Q2 2025 → Q2 2026+5.4M shares+$74.8M
4Q
GEVGEVGE VERNOVA INC
Q3 2025 → Q2 2026+5,964 shares+$8M
4Q
TELTELTE CONNECTIVITY PLC
Q3 2025 → Q2 2026+2,103 shares+$473,241
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used